The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis
G.F.L. Hofbauer, A. Marcollo-Pini, A. Corsenca, A.D. Kistler, L.E. French, R.P. Wüthrich, A.L. SerraVolume:
159
Year:
2008
Language:
english
Pages:
3
DOI:
10.1111/j.1365-2133.2008.08677.x
File:
PDF, 185 KB
english, 2008